These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32087286)

  • 1. JNK signaling activation in the Ube3a maternal deficient mouse model: its specific inhibition prevents post-synaptic protein-enriched fraction alterations and cognitive deficits in Angelman Syndrome model.
    Musi CA; Agrò G; Buccarello L; Camuso S; Borsello T
    Neurobiol Dis; 2020 Jul; 140():104812. PubMed ID: 32087286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology.
    Dindot SV; Antalffy BA; Bhattacharjee MB; Beaudet AL
    Hum Mol Genet; 2008 Jan; 17(1):111-8. PubMed ID: 17940072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult
    Rotaru DC; van Woerden GM; Wallaard I; Elgersma Y
    J Neurosci; 2018 Sep; 38(37):8011-8030. PubMed ID: 30082419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PKA and Ube3a regulate SK2 channel trafficking to promote synaptic plasticity in hippocampus: Implications for Angelman Syndrome.
    Sun J; Liu Y; Zhu G; Cato C; Hao X; Qian L; Lin W; Adhikari R; Luo Y; Baudry M; Bi X
    Sci Rep; 2020 Jun; 10(1):9824. PubMed ID: 32555345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity-dependent changes in MAPK activation in the Angelman Syndrome mouse model.
    Filonova I; Trotter JH; Banko JL; Weeber EJ
    Learn Mem; 2014 Jan; 21(2):98-104. PubMed ID: 24434871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imprinting effects of UBE3A loss on synaptic gene networks and Wnt signaling pathways.
    Lopez SJ; Laufer BI; Beitnere U; Berg EL; Silverman JL; O'Geen H; Segal DJ; LaSalle JM
    Hum Mol Genet; 2019 Nov; 28(22):3842-3852. PubMed ID: 31625566
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Wallace ML; van Woerden GM; Elgersma Y; Smith SL; Philpot BD
    J Neurophysiol; 2017 Jul; 118(1):634-646. PubMed ID: 28468997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of UBE3A-Mediated Regulation of Synaptic SK2 Channels Contributes to Learning and Memory Impairment in the Female Mouse Model of Angelman Syndrome.
    Sun J; Liu Y; Hao X; Baudry M; Bi X
    Neural Plast; 2022; 2022():3923384. PubMed ID: 36237484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards an understanding of Angelman syndrome in mice studies.
    Yang X
    J Neurosci Res; 2020 Jun; 98(6):1162-1173. PubMed ID: 31867793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UBE3A-mediated PTPA ubiquitination and degradation regulate PP2A activity and dendritic spine morphology.
    Wang J; Lou SS; Wang T; Wu RJ; Li G; Zhao M; Lu B; Li YY; Zhang J; Cheng X; Shen Y; Wang X; Zhu ZC; Li MJ; Takumi T; Yang H; Yu X; Liao L; Xiong ZQ
    Proc Natl Acad Sci U S A; 2019 Jun; 116(25):12500-12505. PubMed ID: 31160454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JNK signaling provides a novel therapeutic target for Rett syndrome.
    Musi CA; Castaldo AM; Valsecchi AE; Cimini S; Morello N; Pizzo R; Renieri A; Meloni I; Bonati M; Giustetto M; Borsello T
    BMC Biol; 2021 Dec; 19(1):256. PubMed ID: 34911542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc.
    Greer PL; Hanayama R; Bloodgood BL; Mardinly AR; Lipton DM; Flavell SW; Kim TK; Griffith EC; Waldon Z; Maehr R; Ploegh HL; Chowdhury S; Worley PF; Steen J; Greenberg ME
    Cell; 2010 Mar; 140(5):704-16. PubMed ID: 20211139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motor Deficits Coupled to Cerebellar and Striatal Alterations in Ube3a
    Moreira-de-Sá A; Gonçalves FQ; Lopes JP; Silva HB; Tomé ÂR; Cunha RA; Canas PM
    Mol Neurobiol; 2021 Jun; 58(6):2543-2557. PubMed ID: 33464534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UBE3A regulates the transcription of IRF, an antiviral immunity.
    Furumai R; Tamada K; Liu X; Takumi T
    Hum Mol Genet; 2019 Jun; 28(12):1947-1958. PubMed ID: 30690483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Region-specific impairments in striatal synaptic transmission and impaired instrumental learning in a mouse model of Angelman syndrome.
    Hayrapetyan V; Castro S; Sukharnikova T; Yu C; Cao X; Jiang YH; Yin HH
    Eur J Neurosci; 2014 Mar; 39(6):1018-1025. PubMed ID: 24329862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angelman Syndrome Protein Ube3a Regulates Synaptic Growth and Endocytosis by Inhibiting BMP Signaling in Drosophila.
    Li W; Yao A; Zhi H; Kaur K; Zhu YC; Jia M; Zhao H; Wang Q; Jin S; Zhao G; Xiong ZQ; Zhang YQ
    PLoS Genet; 2016 May; 12(5):e1006062. PubMed ID: 27232889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deleting a UBE3A substrate rescues impaired hippocampal physiology and learning in Angelman syndrome mice.
    Sell GL; Xin W; Cook EK; Zbinden MA; Schaffer TB; O'Meally RN; Cole RN; Margolis SS
    Sci Rep; 2021 Sep; 11(1):19414. PubMed ID: 34593829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic regulation of UBE3A and roles in human neurodevelopmental disorders.
    LaSalle JM; Reiter LT; Chamberlain SJ
    Epigenomics; 2015 Oct; 7(7):1213-28. PubMed ID: 26585570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective glucocorticoid hormone receptor signaling leads to increased stress and anxiety in a mouse model of Angelman syndrome.
    Godavarthi SK; Dey P; Maheshwari M; Jana NR
    Hum Mol Genet; 2012 Apr; 21(8):1824-34. PubMed ID: 22215440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of dopaminergic neurons and resulting behavioural deficits in mouse model of Angelman syndrome.
    Mulherkar SA; Jana NR
    Neurobiol Dis; 2010 Dec; 40(3):586-92. PubMed ID: 20696245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.